PR Newswire BiotechOriginal article
Trevor Kruder, CEO of Paramount Health Rx and Alpha BioMed Industries, Available for Media Commentary on FDA Compounding Advisory Committee Meeting
AdComNeutral
AI Analysis
Summary
Trevor Kruder, CEO of Paramount Health Rx and Alpha BioMed Industries, is available for media commentary regarding an FDA Pharmacy Compounding Advisory Committee meeting scheduled for July 23-24, 2026, to discuss implications for patients and practitioners in peptide care.
Outcome Details
FDA Pharmacy Compounding Advisory Committee meeting scheduled
Importance:3/10
Sentiment:
0.00
FDAAdComcompoundingpeptides
Related Companies
Read the original article
Published by PR Newswire Biotech on July 21, 2026 10:03 AM